Fact CheckerSign in

NCT05591040Recruiting

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia: A Multicentric Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia. This study will be a multicentric randomized, single-blind controlled study. The investigators intend to recruit 100 patients who have suffered a stroke and have dysphagia. Fifty patients will undergo training with bio-feedback (experimental group) and the other fifty patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). Our hypothesis, based on the results obtained in some previous studies, is that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength, timing, coordination and efficacy of the swallowing act.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
7 Oct 2022
Start date
30 Oct 2022
Primary completion date
3 Dec 2027
Lead sponsor
IRCCS San Camillo, Venezia, Italy
Diseases
Stroke
NCT number
NCT05591040

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 30 Oct 2022 to the primary completion date, 3 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;

Other illness

  • All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area);
  • presence of disorders of consciousness;
  • other neurological diseases (for example Parkinson disease)

Other

  • Serious dystonia or unintentional movements
  • encephalopathy due to multiple infarcts;
  • inability to sustain the experimental treatment;

Who the study is looking for

  • first stroke injury
  • onset from more than six weeks
  • presence of dysphagia
  • good comprehension ( not below PT 53 in Token Test)
  • good eyesight and hearing, or adequately corrected

Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sara Nordio
Coordinator of this site? Confirm its status
Venice-LidoItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.